You are currently viewing our desktop site, do you want to download our app instead?
Moneyweb Android App Moneyweb iOS App Moneyweb Mobile Web App

NEW SENS search and JSE share prices

More about the app

Parasite drug analysed as possible Covid treatment in UK trial

Eligible UK participants with Covid-19 symptoms can join the ivermectin trial, which is being evaluated alongside the influenza antiviral favipiravir.
Image: Luis Robayo/AFP/Getty Images

A drug used to treat parasite infections in humans and livestock will be investigated as a possible treatment for Covid-19 in a large UK study at the University of Oxford.

The medicine, known as ivermectin, has antiviral properties and initial preliminary studies have shown it can reduce viral load, the amount of virus in the respiratory tract, and the length of symptoms in those with a mild infection, according to a statement from the university.

Ivermectin has been in use for decades to treat livestock infested with parasitic worms, while in humans it’s used as a topical ointment for diseases including skin infections. It’s already been approved for use on compassionate grounds in a controlled-access program in South Africa, and health authorities have reported widespread use of the drug on the black market. The World Health Organisation and the European Medicines Agency recommend that it only be used in clinical trials, as more data is needed to support its use.

The drug will be analysed as part of the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses, or Principle, the world’s largest clinical trial of potential treatments for the virus in non-hospital settings. Eligible UK participants with Covid-19 symptoms can join the ivermectin trial, which is being evaluated alongside the influenza antiviral favipiravir.

“By including ivermectin in a large-scale trial like Principle, we hope to generate robust evidence to determine how effective the treatment is against Covid-19, and whether there are benefits or harms associated with its use,” said Chris Butler, a professor of medicine at the University of Oxford and one of the study’s lead authors.

© 2021 Bloomberg

COMMENTS   3

Sort by:
  • Oldest first
  • Newest first
  • Top voted

You must be signed in to comment.

SIGN IN SIGN UP

I believe that Ivermectin is produced in India and costs as little as 10cents a dose. How come the population has not been using this during the 3rd wave which has decimated its population. And is Ivermectin the possible cause of the Delta variant as the virus tries to bypass inhibiting factors?
Looking forward to more information.

With a population of over 1.3 billion and deaths of just under 400,000.00, “decimated” is a little hysterical.

Pharmacy down the road sell 10 tablets for R66-00. Need a prescription.

TSK!!!

Best to just get some free Vitamin D.

End of comments.

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR
BTC / USD

Podcasts

INSIDER SUBSCRIPTIONS APP VIDEOS RADIO / LISTEN LIVE SHOP OFFERS WEBINARS NEWSLETTERS TRENDING PORTFOLIO TOOL CPD HUB

Follow us:

Search Articles:
Click a Company: